PharmiWeb.com - Global Pharma News & Resources

Company Directory

PharmiWeb's Pharma Company Directory is a comprehensive and searchable listing of organisations within the Pharma, Biotech & Life Sciences sector. Use it to find partner organisations, suppliers, or even a company to work for!

As an organisation, a basic listing is FREE, and can raise your profile in the industry, making you visible to thousands of monthly site visitors.

To add your organisation to the directory, simply register as a contributor and add your organisation's details. You can also upgrade to a premium listing for only £500/year, this offers even greater scope for added content (more photos, more links, more copy), and even more exposure.

Note that we only accept contributions relating to the Pharma industry and that it will typically take 2 working days to approve (or otherwise) your details. Once approved, you will also be able to contribute press releases and event details to our site.

Create a free account to list your company for free!

Based on priorities set out in our Strategic plan, we invest in research on behalf of the UK tax payer. Our research has resulted in life-changing discoveries for over a hundred years. Scientists apply to the MRC for funding for their research and applications are reviewed by panels of independent experts.
The Medical Science Liaison Society is a 501(c)(3) Non-Profit Organization exclusively dedicated to advancing the global MSL profession. The society serves as a voice for the profession by building further awareness of the important contributions that MSLs make in advancing science which ultimately improves the quality of life for patients.
Medicines Discovery Catapult is a national facility connecting the UK community to accelerate innovative drug discovery. We’re a government funded, not-for-profit organisation, and this financial independence makes us unique. We’re able to take risks and pursue objectives that are understandably challenging for commercial for-profit companies. It’s the reason we’re able to focus so much of our effort on pioneering the next generation of medicine discovery techniques and technologies. By validating new ways of discovering medicines and driving key talent and expertise across the sector, we will support the UK life sciences industry, SMEs and innovators to deliver growth for the UK economy and maintain the UK’s heritage position as a global leader in medicines R&D. Ultimately, new industrialised technologies are vital for delivering new medicines to patients, faster.
The Medicines Evaluation Unit Ltd (MEU) is a clinical research organisation with an outstanding reputation in the conduct of respiratory trials. We are located in a purpose-built, 36-bed research facility on the site of Wythenshawe Hospital.
MMV is a leading product development partnership (PDP) in antimalarial drug research. Its mission is to reduce the burden of malaria in disease-endemic countries by discovering, developing and delivering new, effective and affordable antimalarial drugs.
We’ve been redefining what’s possible in clinical trials for over 20 years. Only Medidata combines the wealth of data, AI powered insights, and patient-centric solutions required to bring tomorrow’s breakthrough therapies and devices to life, and into the hands of patients.
Medigene is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. With its scientific expertise, Medigene is working on the development of innovative immunotherapies to treat cancer such as T cell receptor-modified T cells (TCR‑Ts) or dendritic cell (DC) vaccines in fields of high medical need.
Medivo Limited was incorporated in 2018 in United Kingdom. Medivo provides specialized consultancy medical writing services to medical device and pharmaceutical industries, facilitating clients in Europe, Asia and US.
Medlab Clinical Ltd is an Australian, publicly listed biotechnology company that formulates and enhances viable therapeutic solutions. Our team of scientists, researchers and doctors are dedicated to building products that are scientifically optimised for a better life.
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries.
At Medtronic, we believe in the power of medical technology to improve lives. Seven decades ago, our co-founder invented the battery-powered pacemaker. Today, we are among the largest medical device companies in the world.
In its 10 Research & Development centers, Menarini’s main focus is dedicated to therapeutic areas with unresolved pathologies, such as oncology and anti-infectives (AMR), where increasing treatment options is fundamental to helping those in need.
For 130 years, Merck (known as MSD outside of the U.S. and Canada) has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives.
We are here for people at every step, helping to create, im-prove and prolong life. We deliver personalized treatments for serious diseases and enable people to achieve their dream of becoming parents. We empower the scientific community.
Executive Search and Talent Advisory, existing to make sure organisations always have the right leadership capabilities in place, so they deliver the best possible results.
Meridian HealthComms was created in 2004 with a single purpose in mind: Unlocking complex scientific data to create impactful medical communications. We build strong partnerships with our clients in order to engage with medical experts, share insights and improve clinical practice. It’s at the core of everything we do.
A global, family-owned aesthetics and neurotoxin company inspired by more than 110 years of innovation, commitment and trust. Driven by the opportunity to help people look, feel, and live better, Merz earns the confidence of clinicians in aesthetics and neuroscience with a relentless focus on customer service to providers and overall satisfaction for patients.
The Metrion team has substantial experience of providing high quality drug discovery services for ion channel targets to clients on a fee-for-service or collaboration basis. Metrion is also a leading provider of cardiac safety profiling, cardiac translational assays and neuronal translational assays.